Published in Cytometry A on July 27, 2011
Advances in human B cell phenotypic profiling. Front Immunol (2012) 1.41
RchyOptimyx: cellular hierarchy optimization for flow cytometry. Cytometry A (2012) 1.35
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies. Arthritis Res Ther (2013) 1.07
Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses. J Clin Invest (2013) 0.94
Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response. PLoS One (2015) 0.89
Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut (2015) 0.86
Rationale for B cell targeting in SLE. Semin Immunopathol (2014) 0.86
The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis. JAMA Neurol (2014) 0.84
AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus. Int J Cancer (2014) 0.79
Multiparameter flow cytometry and bioanalytics for B cell profiling in systemic lupus erythematosus. Methods Mol Biol (2012) 0.78
Polychromatic flow cytometry in evaluating rheumatic disease patients. Arthritis Res Ther (2015) 0.76
Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients. Arthritis Res Ther (2016) 0.75
Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections. PLoS One (2016) 0.75
Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS One (2016) 0.75
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med (2008) 5.14
Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol (2008) 2.85
A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol (2007) 2.79
Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest (2005) 2.55
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum (2008) 2.00
B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum (2004) 3.35
A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol (2007) 2.79
Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest (2005) 2.55
Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol (2009) 2.43
Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin Cytom (2010) 2.38
Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum (2004) 2.23
Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol (2009) 2.05
Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum (2007) 2.03
Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy. J Immunol (2010) 1.94
Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J Immunol (2008) 1.62
The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals. J Immunol (2009) 1.50
B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clin Immunol (2006) 1.34
Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol Res (2009) 1.24
Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J Immunol (2004) 1.18
B cells and immunological tolerance. J Invest Dermatol (2009) 1.15
Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults. J Infect Dis (2010) 1.12
Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM. J Immunol (2011) 1.08
B cells in human and murine systemic lupus erythematosus. Curr Opin Rheumatol (2004) 1.02
Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmun Rev (2008) 1.02
Down-regulation of CD20 on B cells upon CD40 activation. Eur J Immunol (2003) 1.01
Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J Immunol (2011) 0.99
Human innate B cells: a link between host defense and autoimmunity? Springer Semin Immunopathol (2005) 0.98
Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes. Biochimie (2012) 0.93
CD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential. J Immunol (2012) 0.90
B-cell-depleting therapy in systemic lupus erythematosus. Am J Med (2012) 0.90
B cell depletion therapy in systemic lupus erythematosus. Curr Rheumatol Rep (2003) 0.87
Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning? Discov Med (2010) 0.87
Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation. Blood (2011) 0.87
Connective tissue diseases: The conundrum of B cell depletion in SLE. Nat Rev Rheumatol (2009) 0.86
Belimumab. Nat Rev Drug Discov (2011) 0.83
Treatment of SLE with anti-CD20 monoclonal antibody. Curr Dir Autoimmun (2005) 0.82
Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol (2012) 0.81
B cell therapies for rheumatoid arthritis: beyond B cell depletion. Rheum Dis Clin North Am (2010) 0.81
AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus. Int J Cancer (2014) 0.79
Connective tissue diseases: targeting B cells in SLE: good news at last! Nat Rev Rheumatol (2011) 0.79
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion. Clin Immunol (2012) 0.79
New therapies for systemic lupus erythematosus: cellular targets. Rheum Dis Clin North Am (2006) 0.78
Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells. Arthritis Rheumatol (2014) 0.77
Snoopology. Hum Behav (1975) 0.75